ICYMI: ChatGPT - A Boon or Threat to Scientific Publication? https://t.co/nt4m6n27A3 https://t.co/oo88u5X86Z

GCA and the Risk of Cerebrovascular Ischemic Events Cerebrovascular ischemic events (CIE) can be one of the most severe complications of giant cell arteritis (GCA), but is seen in 4-5% of GCA patients according to a recent French University Hospital. https://t.co/MAjgWg71vK https://t.co/UhMtiWf7gh

Upadacitinib Outcomes in High Risk RA Patients A safety analysis of six phase III SELECT trials showed that higher-risk RA patients had an increased risk of MACE, malignancy (excluding NMSC) and VTE regardless of being treated with either UPA or ADA. https://t.co/7JXntIV09K https://t.co/CthPcu2Ohs

A double-blind, sham-controlled RCT of auricular vagus nerve stimulation (VNS) showed NO meaningful improvement in 101 RA completers. @week 12, ACR20 was 25% for VNS vs 27% for sham (NS). Also NS was change in DAS28-CRP (–0.95 vs –0.66)(p 0.06) https://t.co/NubTu8mGq4 https://t.co/OQSIpHgLyn

ICYMI: Hydroxychloroquine Dose and Risk for Incident Retinopathy A cohort study in Annals of Internal Medicine shows that higher hydroxychloroquine doses was associated with progressively greater risk for incident retinopathy. https://t.co/SLgUKQKbFs https://t.co/xCc2D5Hx8S

ICYMI: 25 Great Women in Rheumatology https://t.co/ghCAUBMMja https://t.co/cr2xI2VrgE

ICYMI: Carpal Tunnel - Steroid injection vs. Night Splinting A trial conducted by the UK National Health Service, studied interventions in patients with CTS and found no advantage to either CTS CSI or NS as the initial treatment. https://t.co/b8yZSKRK2X https://t.co/zOYaYOtuJd

Pain is the leading cause of disability worldwide. Chronic pain affects 33-50% of the population. High impact chronic pain is seen in 4.8% of US adult population. Chronic pain accounts for 22-50% of GP consultations. More from BMJ.. https://t.co/IRVpJZNS0L https://t.co/YVIM38aWWK

Full read review of "Treatments for Lupus Nephritis" from Isenberg et al - discussing: - Pathogenesis, outcomes - Conventional Rx - B cell targeting: BEL, RTX, Obintuzumab, Atacicept & more - Sequential Rx: Synviose, BEAT, BLISS-Believe - JAKi & more https://t.co/X0xn9FeL0j https://t.co/Fiyf5Drh93

Bringing pivotal clinical trials to you: announcing RheumNow’s Poster Hall, featuring previously presented, sponsor-generated clinical trial posters designed to educate and inform. https://t.co/CeLTCbB2nO https://t.co/qYXt8gCHjd

NIH MOST study 2093 OA pts w/ Knee Xrays/CT/Pain scores q8 mos x2 yrs. IA mineralization seen in 10% knees & assoc w/ a 2 fold higher risk of freq knee pain & OR 1.86 of freq intermit/constant pain. IA mineralz. meniscus or Jt capsule=higher odds of pain https://t.co/CacJ40DVyL https://t.co/Zhwv98d6Pe